In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024 - By Trends, Share, Growth Analysis, Forecast To 2033

"The new report published by The Business Research Company, titled ""In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the in vitro diagnostics (ivd) quality control market size has grown strongly in recent years. It will grow from $1.33 billion in 2023 to $1.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The in vitro diagnostics (ivd) quality control market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample_request?id=5559&type=smp

Rise In Prevalence Of Infectious Diseases Driving Growth Of In Vitro Diagnostics Quality Control Market
The rise in the prevalence of infectious diseases such as HIV and cancer is significantly contributing to the growth of the in vitro diagnostics quality control market. Infectious diseases are common and caused by the transmission of pathogens such as viruses, bacteria, fungi, or parasites. The rise in infectious diseases, including HIV and cancer cases, necessitates novel diagnostic testing goods and services for effective treatment, which is driving up demand for in vitro diagnostics quality control that ensures the accuracy, performance, and quality of test equipment and findings. For instance, according to the Office for National Statistics, a UK-based recognized national statistics institute, in England at the end of the week ending December 9, 2022, the infection rate climbed for people aged 35 to 69 years and increased for those in school years 12 to 24 years. Therefore, the rise in the prevalence of infectious diseases such as HIV and cancer is expected to drive the growth of the in-vitro diagnostics quality control market over the forecast years.

Growing Emphasis On Research And Development Driving Advancements In In Vitro Diagnostics Quality Control
Increasing research and development is shaping the in vitro diagnostics quality control market. Research and development in the market are done for the development, introduction, and optimization of products and processes. For instance, in August 2021, Microbiologics, a US-based biotechnology company introduced a new SARS-CoV-2 quality control (QC) tool for antigen point-of-care (POC) testing. The immobilized SARS-CoV-2 Whole Virus Antigen Control is extremely concentrated and contains fully intact genomic and viral proteins, making it appropriate for antigen testing as well as nucleic acid amplification studies (NAATs). Microbiologics' SARS-CoV-2 Whole Virus Antigen Control is the newest introduction to the company's wide line of In Vitro Diagnostic (IVD) quality controls and Research Use Only (RUO) products developed to aid in the current COVID-19 pandemic response.

The in vitro diagnostics (ivd) quality control market covered in this report is segmented -
1) By Product type: Quality Control Products, Data Management Solutions, Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
4) By End-Users: Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/sample_request?id=5559&type=discount

Major companies operating in the in vitro diagnostics (ivd) quality control market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, SeraCare Life Sciences Inc., Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc., Maine Standards Company LLC

Contents of the report:
1. Executive Summary
2. In Vitro Diagnostics (IVD) Quality Control Market Report Structure
3. In Vitro Diagnostics (IVD) Quality Control Market Trends And Strategies
4. In Vitro Diagnostics (IVD) Quality Control Market - Macro Economic Scenario
5. In Vitro Diagnostics (IVD) Quality Control Market Size And Growth
…..
27. In Vitro Diagnostics (IVD) Quality Control Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.